Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 14894/0567.
Vasran XL 10 mg prolonged-release tablets
Vasran XL 10 mg prolonged-release tablets
Alfuzosin hydrochloride
1. What Vasran XL 10 mg prolonged release tablets are and what they are used for
2. What you need to know before you take Vasran XL 10 mg prolonged release tablets
3. How to take Vasran XL 10 mg prolonged release tablets
4. Possible side effects
5. How to store Vasran XL 10 mg prolonged release tablets
6. Contents of the pack and other information
Alfuzosin is a medicine in the form of a tablet that must be taken via the mouth.
Alfuzosin belongs to a group of medicines, for prostate diseases, called alpha-1- blockers. It promotes relaxation of the muscle tissue in the prostate and urethra, allowing urine to flow out of the bladder more easily.
Alfuzosin is used to treat the symptoms of Benign Prostate Hyperplasia.
Benign Prostate Hyperplasia
The prostate gland lies underneath the bladder. The urethra goes through the prostate to the outside of the body. In addition to glandular tissue (for the production of prostatic fluid), muscle tissue is also present in the prostate. This muscle tissue is also present in the urethra. In Benign Prostate Hyperplasia, this muscle tissue in the prostate and urethra tenses, causing the urethra to narrow. This makes it more difficult for the urine to flow out of the bladder causing lower urinary tract complaints.
Acute Urinary Retention
In a few patients with benign prostatic hyperplasia, the prostate gland gets so big that it stops the flow of urine completely. This is called Acute Urinary Retention.
Talk to your doctor or pharmacist before taking Vasran XL 10 mg prolonged release tablets:
Consult your doctor if one of the above warnings apply to you, or has done in the past.
Alfuzosin is not to be used in children.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
This also applies to medicines that you can obtain without a prescription.
Some medicines may affect each other’s actions or may not be used at the same time for other reasons.
Do not use Vasran XL 10 mg prolonged release tablets if:
Talk to your doctor before taking your medicine if:
Not applicable. Vasran XL 10 mg prolonged release tablets is only prescribed for men.
No known data are available on the effect on the ability to drive or use machines. Complaints such as dizziness or general weakness may occur. This should be taken into account when driving vehicles or using machines.
Vasran XL 10 mg prolonged release tablets contain lactose.
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
For oral use.
The usual dose is one tablet per day.
Vasran XL 10 mg prolonged release tablet will be given to you by your doctor on the day you have the catheter inserted.
You should continue taking Vasran XL 10 mg prolonged release tablet once a day.
Take one tablet of Vasran XL 10 mg prolonged release tablet after the evening meal.
Take the tablet with plenty of fluid (for instance a glass of water). The prolonged-release tablet should not be ground, chewed or divided.
Taking the tablet at the same time every day provides the best effect. It also helps you to remember when to take the tablet.
Your dose does not need to be adjusted for mild to moderate kidney problems whereas it is not given by your doctor in case if you have severe kidney problems.
Vasran XL 10 mg prolonged release tablet should not be used in patients with liver problems. However in mild to moderate liver problems other products containing low dose of alfuzosin can be used according to the appropriate dosage regimen. Your doctor will inform you about this.
The efficacy of Vasran XL 10 mg prolonged release tablet has not been established in children aged 2 to 16 years. Therefore Vasran XL 10 mg prolonged release tablet is not indicated for children and adolescents (2 to 16 years old).
If you take too much Vasran XL 10 mg prolonged release tablets, contact your doctor or pharmacist immediately.
You may forget to take a tablet. In that case it is not necessary to take the forgotten tablet. You can continue to take the prescribed dose the next day.
Do not take a double dose to make up for a forgotten tablet.
You should not interrupt or stop taking Vasran XL 10 mg prolonged release tablets without speaking to your doctor first. Take your tablets as directed and for as long as directed. Do not stop taking them even if you feel better, as otherwise the symptoms may return.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the following happen, stop taking Vasran XL 10 mg prolonged release tablets and tell your doctor immediately or go to your nearest hospital emergency department:
Very rare: (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Each prolonged release tablet contains 10 mg of alfuzosin hydrochloride.
The tablet has a prolonged effect which means that after taking the active substance is not released immediately but gradually from the tablet and therefore acts longer.
Vasran XL 10 mg prolonged release tablets are white to off-white, round, uncoated, biconvex tablets with flattened edges, marked with ‘RY 10’ on one side.
Vasran XL 10 mg prolonged release tablets are available in boxes of 10, 30 or 90 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder:
Manufacturer:
Please contact the marketing authorisation holder if you require more information about this medicine.
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
France ALFUZOSINE CRISTERS PHARMA LP 10 mg comprimés à libération prolongée
Italy Profuzo
Netherlands Alfuzosine HCl SUN 10 mg tabletten, tabletten met verlengde afgifte
Poland Alfabax
United Kingdom (Northern Ireland) Vasran XL 10 mg Prolonged-release Tablets
This leaflet was last revised in November 2023.
V025